Physician profile
Stanley Thornton
NPI 1588870224
$7,243.18
in general payments reported to CMS, 2019-2025
28 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $769 · 2021: $792 · 2022: $1,050 · 2023: $989 · 2024: $1,365 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,188 · Travel and Lodging: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,187.55 |
| Travel and Lodging | $812.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,691.48 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Abbott Laboratories | $1,163.67 | 2019-2025 | Tendyne, Mitraclip, Accent |
| Medtronic Vascular, INC. | $831.30 | 2019-2020 | |
| Edwards Lifesciences Corporation | $645.50 | 2021-2025 | Sapien 3 Ultra Resilia |
| Canon Medical Systems USA, INC. | $372.51 | 2022-2024 | Interventional Angiography System |
| Philips North America LLC | $260.86 | 2021-2022 | |
| Boston Scientific Corporation | $182.54 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.80 | 2021-2024 | Lifevest |
| Penumbra, INC. | $118.17 | 2024-2025 | Indigo System |
| Cardiva Medical, INC. | $113.38 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $111.57 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.11 | 2022 | |
| Abiomed | $74.25 | 2020 | |
| Getinge USA Sales, LLC | $57.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $55.91 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osprey Medical INC | $51.15 | 2019-2020 | |
| Pfizer INC. | $48.57 | 2024 | |
| Sanofi-Aventis U.S. LLC | $45.70 | 2024 | |
| Shockwave Medical, INC | $41.39 | 2020-2022 | |
| Biocompatibles, INC. | $37.46 | 2019 | |
| Amgen INC. | $31.39 | 2019-2022 | |
| Cardiovascular Systems INC. | $25.80 | 2021-2022 | |
| Terumo Medical Corporation | $14.98 | 2025 | Glidewire |
| Reflow Medical INC | $14.65 | 2024 | |
| Novo Nordisk INC | $14.57 | 2022 | |
| Z-Medica, LLC | $13.07 | 2019 | |
| Argon Medical Devices, INC. | $12.40 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.